CN Stock MarketDetailed Quotes

Guangdong Jiaying Pharmaceutical (002198)

Watchlist
  • 4.01
  • +0.04+1.01%
Market Closed May 22 15:00 CST
2.04BMarket Cap74.26P/E (TTM)

Guangdong Jiaying Pharmaceutical (002198) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
1.06%122.92M
2.02%383.75M
13.03%293.44M
10.40%198.94M
28.83%121.63M
-29.46%376.17M
-31.18%259.6M
-30.00%180.2M
-26.52%94.42M
-19.11%533.23M
Operating revenue
1.06%122.92M
2.02%383.75M
13.03%293.44M
10.40%198.94M
28.83%121.63M
-29.46%376.17M
-31.18%259.6M
-30.00%180.2M
-26.52%94.42M
-19.11%533.23M
Other operating revenue
----
-67.45%247.43K
----
-51.35%74.97K
----
281.83%760.11K
----
82.89%154.1K
----
19.52%199.07K
Total operating cost
7.61%109.27M
-2.69%339.8M
3.87%266.45M
-0.60%174.32M
13.92%101.54M
-29.52%349.19M
-26.70%256.53M
-26.20%175.37M
-23.13%89.14M
-17.95%495.41M
Operating cost
64.74%66.51M
2.00%153.73M
15.70%127.9M
-5.52%74.51M
-7.06%40.37M
-18.75%150.72M
-8.07%110.54M
-7.96%78.87M
-2.19%43.44M
-18.82%185.51M
Operating tax surcharges
-16.73%1.63M
5.16%7.56M
5.15%5.04M
4.13%3.39M
15.47%1.96M
-20.72%7.19M
-26.86%4.79M
-25.70%3.26M
-19.24%1.7M
-14.35%9.07M
Operating expense
-30.21%30.85M
-0.50%136.72M
-1.79%102.14M
2.87%72.44M
33.84%44.21M
-43.86%137.4M
-43.83%103.99M
-42.99%70.42M
-43.35%33.03M
-20.39%244.77M
Administration expense
-47.47%7.08M
-31.75%33.09M
-25.14%24.54M
-0.32%19.46M
43.61%13.47M
0.89%48.49M
-0.34%32.78M
-9.50%19.52M
-5.86%9.38M
9.89%48.06M
Financial expense
147.00%78.9K
75.16%-340.2K
71.25%-332.95K
65.63%-289.24K
62.07%-167.88K
34.49%-1.37M
27.41%-1.16M
13.76%-841.55K
9.23%-442.58K
-13.25%-2.09M
-Interest expense (Financial expense)
--84.72K
4,688.80%189.4K
----
----
----
788.09%3.96K
----
-45.21%212.54
--86.07
-99.90%445.34
-Interest Income (Financial expense)
87.08%-23.63K
59.79%-566.42K
65.95%-402.72K
63.04%-318.52K
60.16%-182.88K
33.69%-1.41M
1.10%-1.18M
12.54%-861.84K
8.67%-459.05K
9.10%-2.12M
Research and development
83.83%3.12M
33.73%9.04M
28.37%7.17M
15.95%4.81M
-16.34%1.7M
-33.09%6.76M
-17.15%5.58M
20.29%4.15M
22.56%2.03M
-34.17%10.1M
Credit Impairment Loss
----
107.20%290.05K
-266.26%-1.3M
-330.00%-1.3M
----
-679.68%-4.03M
-162.96%-353.87K
-153.46%-301.41K
----
126.44%695.26K
Asset Impairment Loss
----
-219.49%-3.8M
----
----
----
-44.42%-1.19M
-31.15%-854.42K
-181.44%-1.23M
----
-19.47%-824.24K
Other net revenue
18.98%-616.95K
-137.24%-4.09M
-181.94%-1.35M
-169.45%-1.11M
-178.09%-761.44K
-163.95%-1.72M
-16.32%1.64M
-5.40%1.6M
70.25%975.02K
276.14%2.7M
Fair value change income
-92.38%-961.01K
----
----
-321.95%-361.67K
---499.54K
----
--127.44K
--162.95K
----
103.19%529.95K
Invest income
159.84%210.8K
-324.22%-1.51M
-119.84%-117.2K
-57.97%415.66K
62.04%-352.28K
16.71%675.01K
254.33%590.77K
573.78%988.88K
-14.11%-928.15K
42.70%578.37K
-Including: Investment income associates
----
38.57%-2.33M
30.78%-1.94M
40.63%-1.06M
----
-49.72%-3.79M
-59.53%-2.8M
-45.40%-1.78M
-2.59%-964.27K
-109.04%-2.53M
Asset deal income
----
-108.36%-134.32K
-108.38%-134.62K
-99.99%120.92
-99.99%120.92
1,088.07%1.61M
63.28%1.61M
--1.6M
--1.6M
1,415.68%135.26K
Other revenue
47.64%133.26K
-11.78%1.07M
-61.48%202.3K
-65.69%129.18K
-70.00%90.26K
-23.12%1.22M
-63.79%525.23K
-73.47%376.53K
-78.29%300.92K
39.45%1.58M
Operating profit
-32.58%13.03M
57.82%39.86M
443.95%25.64M
265.56%23.5M
208.99%19.33M
-37.66%25.26M
-83.86%4.71M
-70.05%6.43M
-52.32%6.26M
-24.81%40.52M
Add:Non operating Income
-54.07%45.47K
-94.45%16.16K
-37.65%169.54K
-39.09%165.62K
347.64%99K
28.91%291.26K
75.89%271.92K
314.43%271.92K
-51.80%22.12K
13.09%225.94K
Less:Non operating expense
-97.87%1.86K
324.50%1.93M
-61.31%69.02K
-35.90%69K
226.77%86.92K
-66.82%453.78K
-76.11%178.37K
-83.83%107.65K
677.30%26.6K
-54.20%1.37M
Total profit
-32.40%13.07M
51.23%37.95M
435.45%25.74M
257.92%23.6M
209.40%19.34M
-36.26%25.1M
-83.20%4.81M
-68.40%6.59M
-52.51%6.25M
-22.94%39.37M
Less:Income tax cost
-84.31%617.44K
66.69%7.47M
104.07%3.95M
279.88%3.52M
268.43%3.94M
-11.28%4.48M
-47.77%1.93M
-64.63%925.37K
9.40%1.07M
-29.45%5.05M
Net profit
-19.13%12.46M
47.87%30.48M
658.50%21.79M
254.33%20.08M
197.23%15.4M
-39.94%20.61M
-88.46%2.87M
-68.94%5.67M
-57.47%5.18M
-21.88%34.32M
Net profit from continuing operation
-19.13%12.46M
47.87%30.48M
658.50%21.79M
254.33%20.08M
197.23%15.4M
-39.94%20.61M
-88.46%2.87M
-68.94%5.67M
-57.47%5.18M
-21.88%34.32M
Net profit of parent company owners
-19.13%12.46M
47.87%30.48M
658.50%21.79M
254.33%20.08M
197.23%15.4M
-39.94%20.61M
-88.46%2.87M
-68.94%5.67M
-57.47%5.18M
-21.88%34.32M
Earning per share
Basic earning per share
-35.20%0.0197
48.03%0.0601
652.63%0.0429
253.57%0.0396
198.04%0.0304
-39.94%0.0406
-88.39%0.0057
-68.89%0.0112
-57.50%0.0102
-21.94%0.0676
Diluted earning per share
-35.20%0.0197
48.03%0.0601
652.63%0.0429
253.57%0.0396
198.04%0.0304
-39.94%0.0406
-88.39%0.0057
-68.89%0.0112
-57.50%0.0102
-21.94%0.0676
Other composite income
-2.48M
-1.48M
-1.01M
-1.06M
Other composite income of parent company owners
---2.48M
---1.48M
---1.01M
---1.06M
----
----
----
----
----
----
Total composite income
-35.23%9.98M
40.68%29M
623.31%20.78M
235.58%19.02M
197.23%15.4M
-39.94%20.61M
-88.46%2.87M
-68.94%5.67M
-57.47%5.18M
-21.88%34.32M
Total composite income of parent company owners
-35.23%9.98M
40.68%29M
623.31%20.78M
235.58%19.02M
197.23%15.4M
-39.94%20.61M
-88.46%2.87M
-68.94%5.67M
-57.47%5.18M
-21.88%34.32M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Adverse Opinion
--
--
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
Auditor
--
Zhonghua Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghua Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghua Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 1.06%122.92M2.02%383.75M13.03%293.44M10.40%198.94M28.83%121.63M-29.46%376.17M-31.18%259.6M-30.00%180.2M-26.52%94.42M-19.11%533.23M
Operating revenue 1.06%122.92M2.02%383.75M13.03%293.44M10.40%198.94M28.83%121.63M-29.46%376.17M-31.18%259.6M-30.00%180.2M-26.52%94.42M-19.11%533.23M
Other operating revenue -----67.45%247.43K-----51.35%74.97K----281.83%760.11K----82.89%154.1K----19.52%199.07K
Total operating cost 7.61%109.27M-2.69%339.8M3.87%266.45M-0.60%174.32M13.92%101.54M-29.52%349.19M-26.70%256.53M-26.20%175.37M-23.13%89.14M-17.95%495.41M
Operating cost 64.74%66.51M2.00%153.73M15.70%127.9M-5.52%74.51M-7.06%40.37M-18.75%150.72M-8.07%110.54M-7.96%78.87M-2.19%43.44M-18.82%185.51M
Operating tax surcharges -16.73%1.63M5.16%7.56M5.15%5.04M4.13%3.39M15.47%1.96M-20.72%7.19M-26.86%4.79M-25.70%3.26M-19.24%1.7M-14.35%9.07M
Operating expense -30.21%30.85M-0.50%136.72M-1.79%102.14M2.87%72.44M33.84%44.21M-43.86%137.4M-43.83%103.99M-42.99%70.42M-43.35%33.03M-20.39%244.77M
Administration expense -47.47%7.08M-31.75%33.09M-25.14%24.54M-0.32%19.46M43.61%13.47M0.89%48.49M-0.34%32.78M-9.50%19.52M-5.86%9.38M9.89%48.06M
Financial expense 147.00%78.9K75.16%-340.2K71.25%-332.95K65.63%-289.24K62.07%-167.88K34.49%-1.37M27.41%-1.16M13.76%-841.55K9.23%-442.58K-13.25%-2.09M
-Interest expense (Financial expense) --84.72K4,688.80%189.4K------------788.09%3.96K-----45.21%212.54--86.07-99.90%445.34
-Interest Income (Financial expense) 87.08%-23.63K59.79%-566.42K65.95%-402.72K63.04%-318.52K60.16%-182.88K33.69%-1.41M1.10%-1.18M12.54%-861.84K8.67%-459.05K9.10%-2.12M
Research and development 83.83%3.12M33.73%9.04M28.37%7.17M15.95%4.81M-16.34%1.7M-33.09%6.76M-17.15%5.58M20.29%4.15M22.56%2.03M-34.17%10.1M
Credit Impairment Loss ----107.20%290.05K-266.26%-1.3M-330.00%-1.3M-----679.68%-4.03M-162.96%-353.87K-153.46%-301.41K----126.44%695.26K
Asset Impairment Loss -----219.49%-3.8M-------------44.42%-1.19M-31.15%-854.42K-181.44%-1.23M-----19.47%-824.24K
Other net revenue 18.98%-616.95K-137.24%-4.09M-181.94%-1.35M-169.45%-1.11M-178.09%-761.44K-163.95%-1.72M-16.32%1.64M-5.40%1.6M70.25%975.02K276.14%2.7M
Fair value change income -92.38%-961.01K---------321.95%-361.67K---499.54K------127.44K--162.95K----103.19%529.95K
Invest income 159.84%210.8K-324.22%-1.51M-119.84%-117.2K-57.97%415.66K62.04%-352.28K16.71%675.01K254.33%590.77K573.78%988.88K-14.11%-928.15K42.70%578.37K
-Including: Investment income associates ----38.57%-2.33M30.78%-1.94M40.63%-1.06M-----49.72%-3.79M-59.53%-2.8M-45.40%-1.78M-2.59%-964.27K-109.04%-2.53M
Asset deal income -----108.36%-134.32K-108.38%-134.62K-99.99%120.92-99.99%120.921,088.07%1.61M63.28%1.61M--1.6M--1.6M1,415.68%135.26K
Other revenue 47.64%133.26K-11.78%1.07M-61.48%202.3K-65.69%129.18K-70.00%90.26K-23.12%1.22M-63.79%525.23K-73.47%376.53K-78.29%300.92K39.45%1.58M
Operating profit -32.58%13.03M57.82%39.86M443.95%25.64M265.56%23.5M208.99%19.33M-37.66%25.26M-83.86%4.71M-70.05%6.43M-52.32%6.26M-24.81%40.52M
Add:Non operating Income -54.07%45.47K-94.45%16.16K-37.65%169.54K-39.09%165.62K347.64%99K28.91%291.26K75.89%271.92K314.43%271.92K-51.80%22.12K13.09%225.94K
Less:Non operating expense -97.87%1.86K324.50%1.93M-61.31%69.02K-35.90%69K226.77%86.92K-66.82%453.78K-76.11%178.37K-83.83%107.65K677.30%26.6K-54.20%1.37M
Total profit -32.40%13.07M51.23%37.95M435.45%25.74M257.92%23.6M209.40%19.34M-36.26%25.1M-83.20%4.81M-68.40%6.59M-52.51%6.25M-22.94%39.37M
Less:Income tax cost -84.31%617.44K66.69%7.47M104.07%3.95M279.88%3.52M268.43%3.94M-11.28%4.48M-47.77%1.93M-64.63%925.37K9.40%1.07M-29.45%5.05M
Net profit -19.13%12.46M47.87%30.48M658.50%21.79M254.33%20.08M197.23%15.4M-39.94%20.61M-88.46%2.87M-68.94%5.67M-57.47%5.18M-21.88%34.32M
Net profit from continuing operation -19.13%12.46M47.87%30.48M658.50%21.79M254.33%20.08M197.23%15.4M-39.94%20.61M-88.46%2.87M-68.94%5.67M-57.47%5.18M-21.88%34.32M
Net profit of parent company owners -19.13%12.46M47.87%30.48M658.50%21.79M254.33%20.08M197.23%15.4M-39.94%20.61M-88.46%2.87M-68.94%5.67M-57.47%5.18M-21.88%34.32M
Earning per share
Basic earning per share -35.20%0.019748.03%0.0601652.63%0.0429253.57%0.0396198.04%0.0304-39.94%0.0406-88.39%0.0057-68.89%0.0112-57.50%0.0102-21.94%0.0676
Diluted earning per share -35.20%0.019748.03%0.0601652.63%0.0429253.57%0.0396198.04%0.0304-39.94%0.0406-88.39%0.0057-68.89%0.0112-57.50%0.0102-21.94%0.0676
Other composite income -2.48M-1.48M-1.01M-1.06M
Other composite income of parent company owners ---2.48M---1.48M---1.01M---1.06M------------------------
Total composite income -35.23%9.98M40.68%29M623.31%20.78M235.58%19.02M197.23%15.4M-39.94%20.61M-88.46%2.87M-68.94%5.67M-57.47%5.18M-21.88%34.32M
Total composite income of parent company owners -35.23%9.98M40.68%29M623.31%20.78M235.58%19.02M197.23%15.4M-39.94%20.61M-88.46%2.87M-68.94%5.67M-57.47%5.18M-21.88%34.32M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Adverse Opinion------Unqualified opinion with explanatory notes------Unqualified opinion
Auditor --Zhonghua Certified Public Accountants (Special General Partnership)------Zhonghua Certified Public Accountants (Special General Partnership)------Zhonghua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More